Title 845
Board of Podiatric Medicine |
| DIN: 20160810-IR-845150416FRA
(
HTML
- PDF
)
|
| Type: FR
Posted: 08/10/2016
LSA Doc #15-416
Title 845
|
|
Adds 845 IAC 2 to establish requirements for the prescribing of opioid controlled substances for pain management. Effective 30 days after filing with the Publisher.
|
|
| DIN: 20160715-IR-845150416AFA
(
HTML
- PDF
)
|
| Type: AF
Posted: 07/15/2016
LSA Doc #15-416
Title 845
|
| Publisher's receipt for LSA Document #15-416(F) |
|
| DIN: 20160420-IR-845150416EIA
(
HTML
- PDF
)
|
| Type: EI
Posted: 04/20/2016
LSA Doc #15-416
Title 845
|
|
Economic Impact Statement
LSA Document #15-416
|
|
| DIN: 20160420-IR-845150416PHA
(
HTML
- PDF
)
|
| Type: PH
Posted: 04/20/2016
LSA Doc #15-416
Title 845
|
|
Notice of Public Hearing
LSA Document #15-416
|
|
| DIN: 20160420-IR-845150416PRA
(
HTML
- PDF
)
|
| Type: PR
Posted: 04/20/2016
LSA Doc #15-416
Title 845
|
|
Adds 845 IAC 2 to establish requirements for the prescribing of opioid controlled substances for pain management. Effective 30 days after filing with the Publisher.
|
|
| DIN: 20151125-IR-845150416NIA
(
HTML
- PDF
)
|
| Type: NI
Posted: 11/25/2015
LSA Doc #15-416
Title 845
|
|
OVERVIEW: Adds 845 IAC 2 to establish standards and protocols for the prescribing of controlled substances by podiatrists, consistent with standard medical practices in pain management treatment, inc... |
|